Q: Hi, Pat. Could I have your opinion on the ALPS Sector Dividend Dogs ETF? If one were considering a “Dogs of the Dow” approach, would this be an alternative? Thanks.

A: The ALPS Sector Dividend Dogs ETF, $43.27, symbol SDOG on New York (Units outstanding: 49.3 million; Market cap: $2.1 billion; www.alpssectordividenddogs.com), is an ETF that applies the “Dogs of the Dow” theory on a sector-by-sector basis using the stocks in the S&P 500. The… Read More

These ETFs aim for value stocks

Here are two ETFs that emphasize value investing in their stock selection. Academic studies suggest that, on average, value stocks can produce better results than growth investing. Still, it’s important to look closely to see if they’re truly undervalued. They may, after all, only be… Read More

Two more pet-related spinoffs on tap

ELI LILLY & CO. $105 (New York symbol LLY; Manufacturing & Industry sector; Shares outstanding: 1.1 billion; Market cap: $115.5 billion; Dividend yield: 2.1%; Takeover Target Rating: Low; www.lilly.com) develops, makes and markets drugs and animal-health products.
Lilly hopes to match the success Pfizer realized with its Zoetis spinoff… Read More

Spinoff Spotlight

GLAXOSMITHKLINE PLC (ADR) $42 (New York symbol GSK; Manufacturing & Industry sector; ADRs outstanding: 2.5 billion; Market cap: $105.0 billion; Dividend yield: 3.8%; Takeover Target Rating: Low; www.gsk.com) is a U.K.-based global health-care company that develops, makes and sells products in three main markets: pharmaceuticals, vaccines and consumer… Read More

Second spinoff set to unlock value

Pfizer’s shares have gained 50% in the five years since it used an initial public offering to set up its animal-drug business as Zoetis. It then offered its remaining shares to investors. The new company now plans to sell or spin off its consumer business,… Read More